Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells

Journal of Proteome Research

Volumn 9, Issue 11, 2010, Pages 6007-6015

  Xiong, Lei ^a   Zhang, Jing ^a,b   Yuan, Bifeng ^a   Dong, Xiaoli ^a   Jiang, Xinning ^c   Wang, Yinsheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHAANXI NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chronic myeloid leukemia; erythroid differentiation; histone acetylation; imatinib; SILAC

Indexed keywords

AMINO ACID DERIVATIVE; BCR ABL PROTEIN; BIOLOGICAL MARKER; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; HISTONE H4; IMATINIB; METHIONINE ADENOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; STABLE ISOTOPE; THYMIDYLATE SYNTHASE;

ACETYLATION; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ISOTOPE LABELING; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

ACETYLATION; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HISTONES; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PROTEOMICS; PYRIMIDINES;

EID: 78149396772     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100814y     Document Type: Article

References (30)

1. Rowley, J. D. New consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining Nature 1973, 243, 290-293
2. Sherbenou, D. W.; Druker, B. J. Applying the discovery of the Philadelphia chromosome J. Clin. Invest. 2007, 117, 2067-74
3. + cells Blood 2004, 103, 3167-3174
4. L J. Exp. Hematol. 2000, 191, 977-784
5. Savage, D. G.; Antman, K. H. Drug therapy: Imatinib mesylate-A new oral targeted therapy N. Eng. J. Med. 2002, 346, 683-693
6. Balabanov, S.; Gontarewicz, A.; Ziegler, P.; Hartmann, U.; Kammer, W.; Copland, M.; Brassat, U.; Priemer, M.; Hauber, I.; Wilhelm, T.; Schwarz, G.; Kanz, L.; Bokemeyer, C.; Hauber, J.; Holyoake, T. L.; Nordheim, A.; Brummendorf, T. H. Hypusination of eukaryotic imtiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach Blood 2007, 109, 1701-1711
7. Smith, D. L.; Evans, C. A.; Pierce, A.; Gaskell, S. J.; Whetton, A. D. Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulation Mol. Cell. Proteomics 2002, 1, 876-884
8. Unwin, R. D.; Sternberg, D. W.; Lu, Y. N.; Pierce, A.; Gilliland, D. G.; Whetton, A. D. Global effects of BCR/ABL and TEL/PDGFR beta expression on the proteome and phosphoproteome-Identification of the rho pathway as a target of BCR/ABL J. Biol. Chem. 2005, 280, 6316-6326
9. Ong, S. E.; Mann, M. Mass spectrometry-based proteomics turns quantitative Nat. Chem. Biol. 2005, 1, 252-62
10. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture SILAC as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1, 376-386
11. Liang, X. Q.; Hajivandi, M.; Veach, D.; Wisniewski, D.; Clarkson, B.; Resh, M. D.; Pope, R. M. Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to imatinib treatment in human chronic myelogenous leukemia cells Proteomics 2006, 6, 4554-4564
12. Xiong, L.; Ping, L. Y.; Yuan, B. F.; Wang, Y. S. Methyl group migration during the fragmentation of singly charged ions of trimethyllysine-containing peptides: Precaution of using MS/MS of singly charged ions for interrogating peptide methylation J. Am. Soc. Mass Spectrom. 2009, 20, 1172-1181
13. Park, S. K.; Venable, J. D.; Xu, T.; Yates, J. R. A quantitative analysis software tool for mass spectrometry-based proteomics Nat. Methods 2008, 5, 319-322
14. McClatchy, D. B.; Liao, L. J.; Park, S. K.; Venable, J. D.; Yates, J. R. Quantification of the synaptosomal proteome of the rat cerebellum during post-natal development Genome Res. 2007, 17, 1378-1388
15. Tabb, D. L.; McDonald, W. H.; Yates, J. R. DTASelect and contrast: Tools for assembling and comparing protein identifications from shotgun proteomics J. Proteome Res. 2002, 1, 21-26
16. Uitto, P. M.; Lance, B. K.; Wood, G. R.; Sherman, J.; Baker, M. S.; Molloy, M. P. Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells J. Proteome Res. 2007, 6, 2105-2112
17. Romijn, E. P.; Christis, C.; Wieffer, M.; Gouw, J. W.; Fullaondo, A.; van der Sluijs, P.; Braakman, I.; Heck, A. J. R. Expression clustering reveals detailed coexpression patterns of functionally related proteins during B cell differentiation-A proteomic study using a combination of one-dimensional gel electrophoresis, LC-MS/MS, and stable isotope labeling by amino acids in cell culture (SILAC) Mol. Cell. Proteomics 2005, 4, 1297-1310
18. Horikoshi, A.; Takei, K.; Sawada, S. Relationship between daily dose of imatinib per square meter and its plasma concentration in patients with chronic-phase chronic myeloid leukemia (CML) Leuk. Res. 2007, 31, 574-575
19. Tsutsumi, Y.; Kanamori, H.; Yamato, H.; Ehira, N.; Miura, T.; Kawamura, T.; Obara, S.; Masauzi, N.; Tanaka, J.; Imamura, M.; Asaka, M. Monitoring of plasma imatinib concentration for the effective treatment of CML patients Leuk. Res. 2004, 28, 1117-1118
20. Fang, G.; Kim, C. N.; Perkins, C. L.; Ramadevi, N.; Winton, E.; Wittmann, S.; Bhalla, K. N. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs Blood 2000, 96, 2246-53
21. Jacquel, A.; Herrant, M.; Legros, L.; Belhacene, N.; Luciano, F.; Pages, G.; Hofman, P.; Auberger, P. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl positive K562 cell line and its differentiation towards the erythroid lineage FASEB J. 2003, 17, 2160-2162
22. Gurvich, N.; Tsygankova, O. M.; Meinkoth, J. L.; Klein, P. S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res. 2004, 64, 1079-86
23. Wei, G. H.; Zhao, G. W.; Song, W.; Hao, D. L.; Lv, X.; Liu, D. P.; Liang, C. C. Mechanisms of human gamma-globin transcriptional induction by apicidin involves p38 signaling to chromatin Biochem. Biophys. Res. Commun. 2007, 363, 889-94
24. Prabhu, S.; Saadat, D.; Zhang, M.; Halbur, L.; Fruehauf, J. P.; Ong, S. T. A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation Oncogene 2007, 26, 1188-1200
25. Ly, C.; Arechiga, A. F.; Melo, J. V.; Walsh, C. M.; Ong, S. T. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin Cancer Res. 2003, 63, 5716-5722
26. Kouzarides, T. Chromatin modifications and their function Cell 2007, 128, 693-705
27. Carreras, C. W.; Santi, D. V. The catalytic mechanism and structure of thymidylate synthase Annu. Rev. Biochem. 1995, 64, 721-762
28. Lee, J. H.; Park, J. H.; Jung, Y.; Kim, J. H.; Jong, H. S.; Kim, T. Y.; Bang, Y. J. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Mol. Cancer Ther. 2006, 5, 3085-3095
29. D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G. G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions Biochem. J. 1999, 342, 249-268
30. Moehring, A.; Wohlbold, L.; Aulitzky, W. E.; van der Kuip, H. Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death Cell Death Differ. 2005, 12, 627-636